1.Core Information

　　The Department of Critical Care Medicine (ICU) serves as a core platform-support discipline within our hospital’s “One Body, Two Wings, Four Beams and Eight Pillars” strategic framework, and is a key specialty in Shenzhen’s high-level hospital construction. The department is an ELSO member unit, a national GCP clinical trial base for medical devices, and has established industry-university-research partnerships with Southern University of Science and Technology and Shenzhen Institutes of Advanced Technology, CAS.  

　　The department has a team of 58 professionals, including 13 physicians, 44 nurses, and 1 rehabilitation therapist. Among them, there are 5 senior consultants, 23 associate consultants, and 30 attending physicians. Over 60% of the nursing staff hold a bachelor’s degree or higher.

　　2.Clinical Services

• Sepsis and Shock: Early goal‑directed therapy, invasive hemodynamic monitoring (PiCCO, Swan-Ganz catheter)  

• Respiratory and Circulatory Failure: Non-invasive/invasive mechanical ventilation (including NAVA), inhaled nitric oxide (iNO), extracorporeal membrane oxygenation (ECMO)  

• Severe Liver Disease and Liver Failure: Artificial liver support systems (plasma exchange, DPMAS)  

• Perioperative Management of Major Surgery and Transplantation: Organ protection and post‑transplant critical care for liver/kidney transplantation  

• Polytrauma and Multiple Organ Failure: Continuous renal replacement therapy (CRRT), bedside critical care ultrasound  

• Donor Organ Function Maintenance: Pathophysiological management of brain-dead donors, organ protection protocols

　　3.Special Features & Advantages

• Extracorporeal Life Support Platform: As an ELSO member, the department has established an ECMO‑centered system for organ dysfunction management and functional restoration, performing one of the highest annual ECMO volumes in Shenzhen.  

• Med‑Engineering Integration and AI: In collaboration with Southern University of Science and Technology and Sino-Han Medical, we have built a platform for AI‑driven medical device development and extracorporeal life support equipment research, pioneering a non‑contact vital sign monitoring‑based early warning system for ICU patients.  

• Comprehensive Transplant Critical Care: Leveraging the hospital’s organ transplant center, we have developed a full-spectrum system encompassing pre-transplant donor assessment/protection, post-transplant early warning, and precision therapies (e.g., cfDNA sequencing for infection and immune monitoring).

　　4.Education & Research

　　The department provides rotation training for standardized residency programs in anesthesiology and internal medicine. It has one master’s supervisor and has trained one master’s student and one postdoctoral fellow (under the “Three Famous Teams” project). Since 2018, it has organized 2 national, 2 provincial, and 5 municipal continuing education programs.  

　　In the past five years, the department has received 2 municipal research grants (¥200,000), published 21 papers (10 SCI papers with a cumulative impact factor of 30), and conducted 2 medical device clinical trials and 10 clinical studies. The discipline leader has published 9 papers in high-impact journals including IEEE‑IoT and Military Medical Research.  

　　Faculty members hold leadership positions in multiple societies, including the Critical Care Medicine Branch of Guangdong Medical Association and the Shock and Sepsis Professional Committee of the Chinese Research Hospital Association.